Voloridge Investment Management
BEAM icon

Voloridge Investment Management’s Beam Therapeutics BEAM Stock Holding History

Voloridge Investment Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-492,430
Closed -$13.7M – 1016
2025
Q4 		$13.7M Sell
492,430
-767,581
-61% -$19.6M 0.05% 486
2025
Q3 		$30.6M Buy
1,260,011
+128,218
+11% +$2.55M 0.1% 237
2025
Q2 		$19.3M Buy
1,131,793
+816,357
+259% +$14.2M 0.07% 334
2025
Q1 		$6.16M Sell
315,436
-97,973
-24% -$2.57M 0.02% 726
2024
Q4 		$10.3M Sell
413,409
-50,253
-11% -$1.28M 0.04% 564
2024
Q3 		$11.4M Buy
463,662
+80,667
+21% +$2.08M 0.04% 546
2024
Q2 		$8.97M Buy
382,995
+146,608
+62% +$3.6M 0.03% 589
2024
Q1 		$7.81M Buy
236,387
+78,139
+49% +$2.43M 0.03% 543
2023
Q4 		$4.31M Buy
+158,248
New +$3.93M 0.02% 662
2023
Q3 		– Sell
-29,161
Closed -$931K – 1380
2023
Q2 		$931K Sell
29,161
-29,655
-50% -$962K ﹤0.01% 1132
2023
Q1 		$1.8M Buy
58,816
+12,820
+28% +$506K 0.01% 1000
2022
Q4 		$1.8M Sell
45,996
-168,224
-79% -$7.53M 0.01% 989
2022
Q3 		$10.2M Sell
214,220
-112,274
-34% -$6.4M 0.06% 435
2022
Q2 		$12.6M Buy
326,494
+248,897
+321% +$9.89M 0.07% 374
2022
Q1 		$4.45M Buy
77,597
+61,595
+385% +$4.04M 0.03% 677
2021
Q4 		$1.27M Buy
16,002
+3,592
+29% +$308K 0.01% 1203
2021
Q3 		$1.08M Sell
12,410
-222,044
-95% -$22.3M 0.01% 1257
2021
Q2 		$30.2M Sell
234,454
-10,187
-4% -$812K 0.21% 115
2021
Q1 		$19.6M Buy
244,641
+67,793
+38% +$6.45M 0.14% 188
2020
Q4 		$14.4M Buy
+176,848
New +$8.7M 0.12% 204

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Voloridge Investment Management's BEAM Position: Q1 2026 in Review

Voloridge Investment Management sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 492,430 shares — an estimated $13.7M sold.

Voloridge Investment Management first reported a position in BEAM in Q4 2020 and held it in 20 quarters. The position peaked at $30.6M in Q3 2025. 253 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Voloridge Investment Management reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 492,430 Beam Therapeutics shares in Q1 2026, an estimated $13.7M.
  • Voloridge Investment Management first reported a position in Beam Therapeutics in Q4 2020 and held it in 20 quarters.
  • Voloridge Investment Management's Beam Therapeutics position peaked at $30.6M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.